BACKGROUND: The purpose of the current study was to examine the effect of an oncologist's exercise recommendation with and without an exercise motivation package on the amount of exercise participation and quality of life (QOL) in survivors of breast and colorectal cancer. METHODS: A total of 162 survivors of early-stage breast and colorectal cancer who completed primary and adjuvant treatments were recruited for the current study. Participants were randomly assigned into 1 of 3 groups: 1) control (59 patients); 2) those receiving an oncologist's exercise recommendation (53 patients); and 3) those receiving an oncologist's exercise recommendation with an exercise motivation package (50 patients). At baseline and after 4 weeks, the level of exercise participation and QOL were assessed. RESULTS: Of the 162 participants, 130 (80.2%) completed the trial. Intention-to-treat analysis indicated that participants who received an oncologist's exercise recommendation with an exercise motivation package significantly increased their level of exercise participation in terms of minutes (47.57 added minutes per week; 95% confidence interval, 9.62-85.52 minutes [P =.022] vs control) and in Metabolic Equivalent of Task (MET)-hours per week (4.14 additional MET-hours per week; 95% confidence interval, 1.70-6.58 MET-hours [P =.004] vs control) compared with the control group. Participants who received only their oncologist's exercise recommendation did not increase their exercise participation level. Further analysis demonstrated that role functioning was significantly improved among participants who received an oncologist's exercise recommendation with an exercise motivation package. CONCLUSIONS: Providing an exercise motivation package in addition to the oncologist's exercise recommendation to increase the level of exercise among survivors of breast and colorectal cancer should be considered.
RCT Entities:
BACKGROUND: The purpose of the current study was to examine the effect of an oncologist's exercise recommendation with and without an exercise motivation package on the amount of exercise participation and quality of life (QOL) in survivors of breast and colorectal cancer. METHODS: A total of 162 survivors of early-stage breast and colorectal cancer who completed primary and adjuvant treatments were recruited for the current study. Participants were randomly assigned into 1 of 3 groups: 1) control (59 patients); 2) those receiving an oncologist's exercise recommendation (53 patients); and 3) those receiving an oncologist's exercise recommendation with an exercise motivation package (50 patients). At baseline and after 4 weeks, the level of exercise participation and QOL were assessed. RESULTS: Of the 162 participants, 130 (80.2%) completed the trial. Intention-to-treat analysis indicated that participants who received an oncologist's exercise recommendation with an exercise motivation package significantly increased their level of exercise participation in terms of minutes (47.57 added minutes per week; 95% confidence interval, 9.62-85.52 minutes [P =.022] vs control) and in Metabolic Equivalent of Task (MET)-hours per week (4.14 additional MET-hours per week; 95% confidence interval, 1.70-6.58 MET-hours [P =.004] vs control) compared with the control group. Participants who received only their oncologist's exercise recommendation did not increase their exercise participation level. Further analysis demonstrated that role functioning was significantly improved among participants who received an oncologist's exercise recommendation with an exercise motivation package. CONCLUSIONS: Providing an exercise motivation package in addition to the oncologist's exercise recommendation to increase the level of exercise among survivors of breast and colorectal cancer should be considered.
Authors: Jae Youn Chung; Dong Hoon Lee; Ji-Hye Park; Mi Kyung Lee; Dong-Woo Kang; Jihee Min; Dong-Il Kim; Duck Hyoun Jeong; Nam Kyu Kim; Jeffrey A Meyerhardt; Lee W Jones; Justin Y Jeon Journal: Support Care Cancer Date: 2013-01-06 Impact factor: 3.603
Authors: Kerry S Courneya; Roanne J Segal; Karen Gelmon; Robert D Reid; John R Mackey; Christine M Friedenreich; Caroline Proulx; Kirstin Lane; Aliya B Ladha; Jeffrey K Vallance; Qi Liu; Yutaka Yasui; Donald C McKenzie Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-12 Impact factor: 4.254
Authors: K S Courneya; C M Friedenreich; H A Quinney; A L A Fields; L W Jones; A S Fairey Journal: Eur J Cancer Care (Engl) Date: 2003-12 Impact factor: 2.520
Authors: Sarah J Hardcastle; Maddison Galliott; Brigid M Lynch; Nga H Nguyen; Paul A Cohen; Ganendra Raj Mohan; Niloufer J Johansen; Christobel Saunders Journal: Int J Behav Med Date: 2019-10
Authors: Tammy K Stump; June K Robinson; Betina Yanez; Frank Penedo; Adaeze Ezeofor; Sheetal Kircher; Bonnie Spring Journal: Cancer Date: 2019-08-26 Impact factor: 6.860
Authors: Heidi Mason; Mary Beth DeRubeis; Nancy Burke; Melissa Shannon; Danielle Karsies; Gregory Wolf; Avi Eisbruch; Francis Worden Journal: World J Clin Oncol Date: 2016-04-10
Authors: Alexander V Ng; Alyson N Cybulski; Ashley A Engel; Paula E Papanek; Megan A Sheffer; Leslie J Waltke; Judy A Tjoe Journal: Support Care Cancer Date: 2016-12-24 Impact factor: 3.603
Authors: Ana Maria Lopez; Lauren Hudson; Nathan L Vanderford; Robin Vanderpool; Jennifer Griggs; Mara Schonberg Journal: Am Soc Clin Oncol Educ Book Date: 2019-05-17
Authors: Michelle Nadler; Daryl Bainbridge; Jennifer Tomasone; Oren Cheifetz; Rosalyn A Juergens; Jonathan Sussman Journal: Support Care Cancer Date: 2017-03-03 Impact factor: 3.603
Authors: Hiroko Kunitake; Marcia M Russell; Ping Zheng; Greg Yothers; Stephanie R Land; Laura Petersen; Louis Fehrenbacher; Jeffery K Giguere; D Lawrence Wickerham; Clifford Y Ko; Patricia A Ganz Journal: J Cancer Surviv Date: 2016-08-25 Impact factor: 4.442